Wooree Bio Co.Ltd (082850) — Capital Reinvestment Ratio
Wooree Bio Co.Ltd (082850) has a Capital Reinvestment Ratio of 0.46x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩14.99 Billion) in capital expenditures (₩6.82 Billion). See 082850 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wooree Bio Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Wooree Bio Co.Ltd's Capital Reinvestment Ratio across 15 annual periods. Check Wooree Bio Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Wooree Bio Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Wooree Bio Co.Ltd from 2008 to 2025. For live market cap and broader valuation context, see 082850 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | ₩34.82 Billion | ₩22.42 Billion | ▼ -72.1% |
| 2024 | 2.31x | ₩36.24 Billion | ₩83.57 Billion | ▲ +452.5% |
| 2023 | 0.42x | ₩26.51 Billion | ₩11.07 Billion | ▲ +34.8% |
| 2022 | 0.31x | ₩43.35 Billion | ₩13.42 Billion | ▲ +33.8% |
| 2021 | 0.23x | ₩50.21 Billion | ₩11.62 Billion | ▼ -6.9% |
| 2020 | 0.25x | ₩69.43 Billion | ₩17.26 Billion | ▼ -32.2% |
| 2019 | 0.37x | ₩65.80 Billion | ₩24.11 Billion | ▼ -85.9% |
| 2018 | 2.59x | ₩10.82 Billion | ₩28.04 Billion | ▲ +115.2% |
| 2017 | 1.20x | ₩27.73 Billion | ₩33.37 Billion | ▲ +16.1% |
| 2014 | 1.04x | ₩54.31 Billion | ₩56.29 Billion | ▼ -18.2% |
| 2013 | 1.27x | ₩80.75 Billion | ₩102.35 Billion | ▼ -75.3% |
| 2011 | 5.12x | ₩8.36 Billion | ₩42.84 Billion | ▲ +9.2% |
| 2010 | 4.69x | ₩17.33 Billion | ₩81.28 Billion | ▲ +666.2% |
| 2009 | 0.61x | ₩46.60 Billion | ₩28.53 Billion | ▲ +5.1% |
| 2008 | 0.58x | ₩69.27 Billion | ₩40.36 Billion | — |